For its second fiscal quarter (ending June 30), DexCom Inc (NASDAQ: DXCM) has reported a 20% increase in E.P.S. from $0.30 a year ago to $0.36 in the current quarter. Relative to the consensus estimate of $0.39, this was a shortfall of $-0.03. For the latest four quarters through June 30, E.P.S. were $1.71 versus $0.93 for the same period a year ago — an increase of 84%.
Recent Price Action
DexCom Inc (NASDAQ: DXCM) stock declined by -3.7% on 7/25/24. The shares closed at $107.85. Moreover, exceptionally high trading volume at 329% of normal accompanied the decline. The stock has performed in line with the market over the last nine months and has declined -5.9% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, DXCM is expected to continue to be a major Value Builder.
DexCom has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. DexCom has a very low Appreciation Score of 12 but a neutral Power Rating of 60, and the Negative Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment